Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-fasting vs Fasting OGTT for HIP Screening
NCT04129190Phase 2Unknown
- Sponsor
- Isra University
- Start
- Oct 2019
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Isra University. Primary endpoint: Oral Glucose Tolerance at 2 hours. Status: unknown.
Beyond the preview
Go deeper on NCT04129190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04129190.